Activists demand access to affordable oral hepatitis drugs

Giving patents to foreign-made medicines will add to patients’ woes, they urge   

86 European, US children down with severe hepatitis; experts perplexed

Some have cited COVID-19 as a reason; some two years of it, while the rest have blamed the adenovirus